Bariatric Surgery Devices Market By Type of Device (Intragastric Balloon Systems, Bariatric Surgery Staples, Gastric Bands, Gastric Bypass Instruments), By Procedure (Sleeve Gastrectomy, Gastric Bypass, Gastric Banding, Duodenal Switch), By End-User (Hospitals, Clinics, Ambulatory Surgical Centers, Homecare Settings), and By Region; Global Insights & Forecast (2024 – 2030)

As per Intent Market Research, the Bariatric Surgery Devices Market was valued at USD 2.3 billion in 2023 and will surpass USD 4.2 billion by 2030; growing at a CAGR of 8.7% during 2024 - 2030.

The bariatric surgery devices market is experiencing robust growth driven by the increasing prevalence of obesity worldwide and the growing awareness around weight management treatments. Bariatric surgery is one of the most effective solutions for long-term weight loss and is gaining traction due to its ability to offer significant health improvements for individuals suffering from obesity. This market is segmented into different types of devices, procedures, and end-users. The most commonly used devices in bariatric surgery include intragastric balloon systems, bariatric surgery staples, gastric bands, gastric bypass instruments, and other surgical devices. Furthermore, the adoption of minimally invasive procedures like sleeve gastrectomy and gastric bypass is rising due to their efficiency and lower risk of complications, particularly in hospitals and surgical centers.

Intragastric Balloon Systems Segment is Fastest Growing Owing to Increasing Non-invasive Preferences

Intragastric balloon systems represent one of the fastest-growing subsegments within the bariatric surgery devices market. These devices offer a non-invasive alternative to traditional weight loss surgeries, making them a popular choice for individuals seeking a less invasive option with shorter recovery times. The procedure involves placing a balloon in the stomach, which helps patients feel fuller and aids in weight loss. The growing awareness of the risks associated with obesity and the increasing preference for non-surgical, reversible options are major drivers for the expansion of this subsegment. Additionally, advancements in balloon technology, improved patient outcomes, and better safety profiles are contributing to its rising adoption, particularly in markets like North America and Europe.

Sleeve Gastrectomy Procedure is Largest Owing to High Adoption Rates

Among the various bariatric surgery procedures, sleeve gastrectomy is the largest in terms of adoption, driven by its effectiveness in weight loss and lower complication rates compared to traditional bariatric surgeries. The procedure involves removing a large portion of the stomach to create a tube-like structure, which reduces food intake and promotes long-term weight loss. As a result, it has become the preferred option for patients and surgeons alike, particularly in countries where access to healthcare is expanding. The high success rate, combined with a relatively shorter hospital stay, has contributed to its prominence. Furthermore, sleeve gastrectomy is increasingly being seen as a first-line treatment for obesity, further boosting its position in the market.

Hospitals Segment is Largest Due to the Complexity of Bariatric Surgeries

Hospitals remain the largest end-user segment in the bariatric surgery devices market due to the complexity and the need for specialized care associated with bariatric surgeries. These surgeries often require an extensive pre-surgical assessment, post-surgery monitoring, and long-term care, making hospitals the most suitable environments for performing them. Hospitals also have the necessary resources, including experienced surgical teams and advanced medical equipment, to handle the intricate nature of bariatric procedures. As the demand for bariatric surgery grows, hospitals will continue to account for a large share of the market, particularly in developed countries where access to advanced healthcare is prevalent.

North America Remains the Largest Region Due to Rising Obesity Rates and Healthcare Advancements

North America continues to be the largest regional market for bariatric surgery devices, driven primarily by the high obesity rates in the U.S. and Canada. The growing focus on health and wellness, along with the increasing acceptance of bariatric surgeries as a medical solution to obesity-related conditions such as type 2 diabetes, hypertension, and sleep apnea, is boosting the market. Additionally, advancements in surgical technologies, the availability of highly trained specialists, and robust healthcare infrastructure further enhance the demand for bariatric surgeries. The increasing healthcare expenditure and the adoption of minimally invasive surgical methods are expected to maintain North America's dominance in the market for the foreseeable future.

Leading Companies and Competitive Landscape

The bariatric surgery devices market is highly competitive, with several key players dominating the landscape. Prominent companies include Medtronic, Johnson & Johnson, Apollo Endosurgery, Intuitive Surgical, and Boston Scientific, all of which have a strong presence in the market. These companies are continuously innovating, focusing on enhancing the safety, efficacy, and convenience of bariatric surgical procedures. Mergers and acquisitions, along with strategic partnerships, are common in the industry as companies aim to expand their product portfolios and tap into emerging markets. The rise of advanced, minimally invasive devices and the growing demand for less invasive procedures are leading to heightened competition. As patient preferences evolve, companies that invest in cutting-edge technologies and improve surgical outcomes are well-positioned to maintain their competitive edge in this growing market.

The increasing focus on personalized and patient-centric care, along with the expansion of healthcare access globally, presents further opportunities for companies in the bariatric surgery devices market to innovate and capture greater market share.

Recent Developments:

• Medtronic Acquires Mazor Robotics – Medtronic has expanded its portfolio in the obesity and bariatrics space by acquiring Mazor Robotics to integrate robotic assistance in weight-loss surgeries, providing more precision in surgeries.
• Apollo Endosurgery Launches New Device for Obesity – Apollo Endosurgery has recently launched a new version of its intragastric balloon device, designed to enhance patient comfort and safety during weight-loss procedures.
• Ethicon Introduces New Bariatric Surgery Stapler – Ethicon has introduced a new stapler designed for bariatric surgery, improving precision and reducing complications during sleeve gastrectomy procedures.
• Stryker Corporation Expands in Bariatrics Market – Stryker Corporation has introduced a new line of minimally invasive bariatric surgical tools aimed at improving recovery times and reducing patient complications.
• Reshape Lifesciences Receives FDA Approval for New Intragastric Balloon – Reshape Lifesciences has gained FDA approval for its new intragastric balloon technology, targeting a wider range of patients with a focus on ease of implantation and patient comfort

List of Leading Companies:

• Johnson & Johnson
• Kimberly-Clark Corporation
• Procter & Gamble
• The Clorox Company
• Reckitt Benckiser Group
• Unicharm Corporation
• Edgewell Personal Care
• Medline Industries
• SC Johnson Professional
• AlcoPro
• Alea Care
• The Honest Company
• VWR International
• Ecolab
• Gojo Industries

Report Scope: